Login / Signup

Validation of preimplantation genetic tests for aneuploidy (PGT-A) with DNA from spent culture media (SCM): concordance assessment and implication.

Baoli YinHuijuan ZhangJuanke XieYubao WeiCuilian ZhangLi Meng
Published in: Reproductive biology and endocrinology : RB&E (2021)
Our study reveals that DNA is detectable in the majority of SCM samples. Individual chromosomal aberration, such as segmental aneuploidy and mosaicism, can be quantitatively and qualitatively measured. However, TE still provides a more accurate and reliable high-throughput methodology for PGT-A. Meanwhile, cell-free DNA in SCM reporting lacks uniform diagnostic interpretations. Considering that this test is meant to determine which embryos are relegated to be discarded, PGT-A with cell-free DNA in SCM should not be permitted to be applied in routine clinical settings for diagnosis purpose.
Keyphrases
  • high throughput
  • circulating tumor
  • cell free
  • single molecule
  • copy number
  • clinical practice
  • high resolution
  • gene expression
  • adverse drug
  • mass spectrometry
  • circulating tumor cells